<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00668850</url>
  </required_header>
  <id_info>
    <org_study_id>GEN-084-OL</org_study_id>
    <nct_id>NCT00668850</nct_id>
  </id_info>
  <brief_title>Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin</brief_title>
  <official_title>A 26-Week, Open-Label, Randomized, Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin In Subjects With Type-1 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Generex Biotechnology Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>OSMOS Clinical Research, Inc</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>PSI Pharma Support Intl</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nextrials, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>eResearch Technology, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hoffmann-La Roche</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>ACM Pivotal Global Central Laboratory</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Generex Biotechnology Corp.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy of Generex Oral-lyn™ RapidMist™ System and standard regular human
      insulin therapy as measured by HbA1c, in type-1 diabetes mellitus subjects on BID NPH
      intermediate acting insulin therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a 26 week open-label, randomized, multi-center, active comparator study to compare
      oral spray insulin (Generex Oral-lyn™) with regular human insulin therapy as measured by
      HbA1c, and number of hypoglycaemic episodes in type-1 diabetes mellitus subject. All subjects
      will be on BID NPH intermediate acting insulin therapy. If subject is using long acting
      insulin (Glargine, Detemir, etc.), he/she must be switched to NPH intermediate acting
      insulin. If on insulin analogue (Novolog, Lispro, Aspart, Aphidra, Glulisine, or any other
      analogue available in the subject's geographical area), the subject must be switched to
      regular human insulin 3 times a day.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2008</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <primary_completion_date type="Anticipated">August 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the efficacy of Generex Oral-lyn™ RapidMist™ System and standard regular human insulin therapy as measured by HbA1c, in type-1 diabetes mellitus subjects on BID NPH intermediate acting insulin therapy</measure>
    <time_frame>change in HbA1c from the Day 0 (V3) to Day 180 (V9) of Treatment Phase.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the safety, tolerability, and satisfaction with Generex Oral-lyn™ therapy when administered by the RapidMist™ Diabetes Management System</measure>
    <time_frame>26 week</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Generex Oral-lyn™ spray in a split-dose fashion (half the dose immediately prior to the meal and half the dose immediately after the meal) + BID NPH insulin AM and PM as pre-randomization dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular human insulin 30 minutes before meals + BID NPH insulin AM and PM as pre-randomization dose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Generex Oral-lyn™</intervention_name>
    <description>Generex Oral-lyn™ spray in a split-dose fashion (half the dose immediately prior to the meal and half the dose immediately after the meal) + BID NPH insulin AM and PM as pre-randomization dose</description>
    <arm_group_label>1</arm_group_label>
    <other_name>buccal Insulin spray</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Regular human insulin</intervention_name>
    <description>Regular human insulin 30 minutes before meals + BID NPH insulin AM and PM as pre-randomization dose.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>insulin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be male or female between the ages 18 to 75 years

          -  Type 1 diabetes mellitus patients (according to ADA and/or WHO classification) who
             have &gt;1 year history of type 1 DM and are currently managed with daily insulin
             injections totalling 0.3 to 0.8 IU/kg of body weight;

          -  Current physical examination, vital signs and ECG at screening that reveals no
             clinically significant abnormalities;

          -  Have a body mass index (BMI) &lt;27;

          -  8.5% (inclusively)&lt;Have a glycosylated haemoglobulin HbA1c

          -  Willing and able to follow the American Diabetes Association diet guidelines for type
             1 diabetes; be able to commit to perform home blood glucose monitoring and record
             values as well as hypoglycemic events

          -  Willing to give written informed consent prior to admission into the study.

        Exclusion Criteria:

          -  Have a significant active asthma or suspected abnormalities of buccal mucosa;
             cardiovascular, cerebrovascular, hepatic, renal, gastrointestinal, hematological, or
             auto-immune disease (other than auto-immune thyroid disease); history of athopy or
             drugs allergy

          -  Have evidence of unstable retinopathy (defined as pre-proliferative or proliferative
             retinopathy currently requiring photocoagulation therapy), nephropathy or neuropathy
             (gastroparesis or orthostatic hypotension);

          -  Have hypoglycemia unawareness;

          -  Have had more than one episode of severe hypoglycemia with seizure or coma or
             ketoacidosis within the past 12 months;

          -  Have a blood pressure in excess of 160/100 mmHg at the Screening visit;

          -  Have had any acute illness within the 2 weeks prior to screening;

          -  Have a history of drug or alcohol abuse that in the opinion of the Investigator would
             interfere with participation in the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerald Bernstein,, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Generex Biotechnology Corp.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jaime Davidson, MD</last_name>
    <role>Study Director</role>
    <affiliation>Generex Biotechnology Corp.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philip Raskin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas, Southwestern Medical Center at Dallas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Coastal Biomedical Research Inc. at Santa Monica</name>
      <address>
        <city>2001 Santa Monica Blvd Suite 390W</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Center for Diabetes &amp; Endocrine Care at Hollywood</name>
      <address>
        <city>1150 N. 35th Ave Suite 590</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Physicians Research Group at Indianapolis</name>
      <address>
        <city>7400 North Shadeland Ave</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MODEL Clinical Research at Baltimore</name>
      <address>
        <city>6535 North Charles Street Suite 400N</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grunberger Diabetes Institute at Bloomfield Hills</name>
      <address>
        <city>43494 Woodward Ave Suite 208</city>
        <state>Michigan</state>
        <zip>48302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Medical Center, Geral J. Friedman Diabetes Institute at New York</name>
      <address>
        <city>317 East 17th Street Room 7F05 8th Floor</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multiple Health Research, LLC. at Arlington</name>
      <address>
        <city>501 Rita Lane Suite 113</city>
        <state>Texas</state>
        <zip>76014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center at Dallas</name>
      <address>
        <city>5323 Harry Hines Blvd</city>
        <state>Texas</state>
        <zip>75390-8858</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment &quot;Aleksandrovska&quot;</name>
      <address>
        <city>1 St. Georgi Sofiysky St</city>
        <state>Sofia</state>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment at Varna</name>
      <address>
        <city>1 Hristo Smirnensky St</city>
        <zip>9010</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for Active Treatment at Stara Zagora</name>
      <address>
        <city>11 Armeyska St.</city>
        <zip>6003</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment at Plovdiv</name>
      <address>
        <city>15A Vassil Aprilov Blvd</city>
        <zip>4002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for Active Treatment at Ruse</name>
      <address>
        <city>2 Nezavisimost St</city>
        <zip>7002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment at Pleven</name>
      <address>
        <city>8A Georgi Kotchev St</city>
        <zip>5800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Bailey Clinic at Red Deer</name>
      <address>
        <city>#108 3947 50A Avenue</city>
        <state>Alberta</state>
        <zip>T4N 6V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Calgary Metabolic Education &amp; Research Centre at Calgary</name>
      <address>
        <city>#23, 4411-16th Avenue NW</city>
        <state>Alberta</state>
        <zip>T3B 0M3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Edmonton Diabetes Centre</name>
      <address>
        <city>10230 142 St Nw # 25, Edmonton</city>
        <state>Alberta</state>
        <zip>T5N 3Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Endocrinologia IEMYR</name>
      <address>
        <city>Avenida La Coruña Nº 6337 y San Ignacio</city>
        <state>Quito</state>
        <country>Ecuador</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bydgoszcz Diabetology and Endocrinology Center at Bydgoszcz</name>
      <address>
        <city>ul. Baczynskiego 17</city>
        <zip>85 - 822</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OSTEOMED Medical Center at Warszawa</name>
      <address>
        <city>ul. Bialobrzeska 40A</city>
        <zip>02 - 341</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chair and Department of Internal Medicine and Diabetology, Voivodship Brodnowski Hospital at Warszawa</name>
      <address>
        <city>ul. Kondratowicza 8</city>
        <zip>03 - 242</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetology Clinic for Adults, NZOZ Elblag Diabetology Center</name>
      <address>
        <city>ul. Krolewiecka 146</city>
        <zip>82 -300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>TeMeD - Clinical Trials at Rzeszow</name>
      <address>
        <city>ul. Mazowiecka 56</city>
        <zip>35-324</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Provincial Centre of Diabetology and Metabolic Diseases, M.Pirogow Provincial Specialist Hospital at Lodz</name>
      <address>
        <city>ul. Nowa 30/32</city>
        <zip>90-030</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Silesia Osteoporosis Center at Katowice</name>
      <address>
        <city>ul. Opolska 11/3</city>
        <zip>40-084</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>TeMeD - Clinical Trials at Nowy Targ</name>
      <address>
        <city>ul. Wojska Polskiego 14</city>
        <zip>34-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ Specialist Centre of Internal Medicine and Diabetology Malgorzata Arciszewska at Bialystok</name>
      <address>
        <city>ul. Zamenhofa 10/20</city>
        <zip>15 - 435</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Celis Aguilera 10B</name>
      <address>
        <city>Fajardo</city>
        <zip>00738</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Puerto Medical Center</name>
      <address>
        <city>San Juan</city>
        <zip>364246</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research, Puerto Rico</name>
      <address>
        <city>San Juan</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Nicolae Malaxa&quot; Clinical Hospital, Department of Diabetes, Nutrition and Metabolic Diseases at Bucharest</name>
      <address>
        <city>12 Vergului St Sector 2</city>
        <zip>022441</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Timisoara Emergency Clinical County Hospital, Clinic of Diabetes, Nutrition and Metabolic Diseases at Timisoara</name>
      <address>
        <city>156 Iosif Bulbuca Av</city>
        <zip>300736</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Satu Mare County Hospital, Department of Diabetology and Nutrition Diseases at Satu Mare</name>
      <address>
        <city>2-3 Eroii Revolutiei Square</city>
        <zip>440055</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practice at Galati</name>
      <address>
        <city>25 Constructorilor St, Bl. E5/64</city>
        <zip>800371</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cluj Emergency Clinical County Hospital, Department of Diabetes, Nutrition and Metabolic Diseases at Cluj-Napoca</name>
      <address>
        <city>3-5 Clinicilor St</city>
        <zip>400006</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oradea Clinical County Hospital, Department of Diabetes, Nutrition and Metabolic Diseases at Oradea</name>
      <address>
        <city>33 Republicii St</city>
        <zip>410032</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Institute of Diabetes, Nutrition and Metabolic Diseases, 1st Clinical Department of Diabetes, Nutrition and Metabolic Diseases at Bucharest</name>
      <address>
        <city>5-7 Ion Movila St Sector 2</city>
        <zip>020475</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Private Practice at Bala Mare</name>
      <address>
        <city>6/72 Independentei St</city>
        <zip>430123</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practice Nicodiab SRL at Bucharest</name>
      <address>
        <city>92 Polona St, Bl 17 A+B, Sc. 1, Ap. 2</city>
        <zip>010507</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Municipal Medical Institution: City Hospital # 2, Municipal Diabetology and Rehabilitation Center</name>
      <address>
        <city>1 3rd -Transportnaya str., Omsk</city>
        <zip>644021</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Petersburg State Medical Institution: St. George Municipal Hospital</name>
      <address>
        <city>1 Severny Pr., St.Petersburg</city>
        <zip>194354</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Municipal Medical Institution: Medical Unit &quot;Izhmash&quot;, Municipal Endocrinology Center</name>
      <address>
        <city>1 Truda str., Izhevsk</city>
        <zip>426067</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Petersburg State Medical Institution: Municipal Consulting and Diagnostic Center #1, St. Petersburg Territorial Diabetology Center</name>
      <address>
        <city>10 Siqueirosa str., St. Petersburg</city>
        <zip>194354</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federal State Institution: Endocrinology Research Center under the Federal Agency for High-Tech Medical Care, Department of Therapeutic and Surgical Methods for Treatment of Diabetic Foot</name>
      <address>
        <city>11 Dmitriya Ulyanova str., Moscow</city>
        <zip>117036</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federal State Institution: Endocrinology Research Center under the Federal Agency for High-Tech Medical Care, Department of Training and Psychosocial Rehabilitation of Patients with Diabetes Mellitus</name>
      <address>
        <city>11 Dmitriya Ulyanova str., Moscow</city>
        <zip>117036</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Petersburg State Medical Institution: Municipal Hospital of St. Elizabeth</name>
      <address>
        <city>14 Vavilovykh str., St. Petersburg</city>
        <zip>195257</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Medical Institution: Nizhny Novgorod Regional Clinical Hospital n.a. N.A. Semashko</name>
      <address>
        <city>190 Rodionova str., Nizhny Novgorod</city>
        <zip>603126</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Institution Municipal Clinical Hospital #67</name>
      <address>
        <city>2 &quot;b&quot; Salyama Adilya str., Moscow</city>
        <zip>123423</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Medical Institution: Kemerovo Regional Clinical Hospital</name>
      <address>
        <city>22 Oktyabrsky Pr., Kemerovo</city>
        <zip>650066</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Medical Institution: Arkhangelsk Regional Clinical Hospital</name>
      <address>
        <city>292 Lomonosova pr., Arkhangelsk</city>
        <zip>163045</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Medical Institution: Republican Hospital</name>
      <address>
        <city>3 Pirogova str., Petrozavodsk, ,</city>
        <zip>185019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Petersburg State Medical Institution:Municipal Outpatient Clinic #51</name>
      <address>
        <city>33/35 Kosmonavtov Pr., St. Petersburg</city>
        <zip>196211</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Moscow State Medical Institution Municipal Clinical Hospital #68</name>
      <address>
        <city>4 Shkuleva str., Moscow</city>
        <zip>109263</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Petersburg State Medical Institution: City Aleksandrovskaya Hospital</name>
      <address>
        <city>4 Solidarnosti Pr., St. Petersburg</city>
        <zip>193312</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federal State Medical Institution: All-Russia Center for Urgent Care and Radiation Medicine n.a. A.M. Nikiforov under the Russian Emergency Control Ministry</name>
      <address>
        <city>4/2 Lebedeva str., St.Petersburg</city>
        <zip>194044</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Petersburg State Medical Institution: Municipal Multifield Hospital #2</name>
      <address>
        <city>5 Uchebny Per., St. Petersburg</city>
        <zip>194354</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Higher Educational Institution: Tyumen State Medical Academy under the Federal Agency for Healthcare and Social Development, Multifield Clinic</name>
      <address>
        <city>54 Odesskaya str., Tyumen</city>
        <zip>625023</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Diabetes&quot; Center Company Limited</name>
      <address>
        <city>56 Sovetskoi Armii str., Samara</city>
        <zip>443067</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Medical Institution: Consulting and Diagnostic Center of Komi Republic, Diabetology Center</name>
      <address>
        <city>6 Kuratova str., 167981</city>
        <zip>Syktyvkar</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Medical Institution: Murmansk Regional Consulting and Diagnostic Center</name>
      <address>
        <city>6 Pavlova str., Building 4, Murmansk</city>
        <zip>183047</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Municipal Medical Institution: Municipal Clinical Hospital #1, Municipal Diabetology Center</name>
      <address>
        <city>6 Zalesskogo str., Novosibirsk</city>
        <zip>630047</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Higher Educational Institution: St. Petersburg State Medical University n.a. I.P. Pavlov under the Federal Agency for Healthcare and Social Development</name>
      <address>
        <city>6/8 L. Tolstogo str., St. Petersburg</city>
        <zip>197022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Institution: Moscow Regional Research Clinical Institute n.a. M.F.Vladimirsky</name>
      <address>
        <city>61/2 Shchepkina str., Moscow</city>
        <zip>129110</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Higher Educational Institution: Ural State Medical Academy under the Federal Agency for Healthcare and Social Development; Family Medicine Clinic</name>
      <address>
        <city>7 Kluchevskaya str., Ekaterinburg</city>
        <zip>620219</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Medical Healthcare Institution: Chelyabinsk Regional Clinical Hospital</name>
      <address>
        <city>70 Vorovskogo str., Medgorodok, Chelyabinsk</city>
        <zip>454076</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Medical Institution:Territorial Endocrinology Center, Territorial Diabetology Center</name>
      <address>
        <city>9 Artema str., Stavropol</city>
        <zip>355045</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Endocrinology Center, Diabetology Department at Lviv</name>
      <address>
        <city>1, Ostrozskoho St., Lviv</city>
        <zip>79010</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ukrainian Research and Development Center for Endocrine Surgery and Endocrine Organ and Tissue Transplantation under the Ministry of Health of Ukraine, General Endocrine Pathology Department at Kiev</name>
      <address>
        <city>121, Kharkovskoe Shosse, Kiev</city>
        <zip>02175</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>M.V. Sklifosovskyi Regional Clinical Hospital, Endocrinology Department at Poltava</name>
      <address>
        <city>23, Shevchenko St.</city>
        <zip>36024</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital #9, Endocrinology Department at Dnipropetrovsk</name>
      <address>
        <city>29, Vorontsova St.</city>
        <zip>49023</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>M.O. Semashko Republican Clinical Hospital, Endocrinology Department at Simferopol</name>
      <address>
        <city>69 Kievskaya St.</city>
        <zip>95017</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>V.P. Komisarenko Institute for Endocrinology and Metabolism under the Ukrainian Academy of Medical Sciences, Clinical Diabetology Department at Kiev</name>
      <address>
        <city>69, Vyshgorodskaya St., Kiev</city>
        <zip>04114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>V.P. Komisarenko Institute for Endocrinology and Metabolism under the Ukrainian Academy of Medical Sciences, General Endocrine Pathology Department at Kiev</name>
      <address>
        <city>69, Vyshgorodskaya St., Kiev</city>
        <zip>04114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>V.Ya. Danylevskyi Institute for Endocrine Pathology under the Ukrainian Academy of Medical Sciences, Clinical Endocrinology Department at Kharkov</name>
      <address>
        <city>Pomerky 27, Kharkov</city>
        <zip>61070</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Ecuador</country>
    <country>Poland</country>
    <country>Puerto Rico</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2008</study_first_submitted>
  <study_first_submitted_qc>April 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2008</study_first_posted>
  <last_update_submitted>June 6, 2011</last_update_submitted>
  <last_update_submitted_qc>June 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2011</last_update_posted>
  <responsible_party>
    <name_title>George E. Markus</name_title>
    <organization>Generex Biotechnology Corp.</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Isophane insulin, beef</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin, Isophane</mesh_term>
    <mesh_term>Isophane Insulin, Human</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 20, 2013</submitted>
    <returned>May 2, 2013</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

